What is CRVS's dilution risk score?

CRVS has a latest available DilutionScore record of 59/100, categorized as high dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for CRVS, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for CRVS?

DilutionWatch tracks 25 SEC filing types for CRVS including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect CRVS shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For CRVS, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for CRVS tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for CRVS. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

CRVS Dilution Risk Score: 59/100 (HIGH)

Score Breakdown

📋 Offering Ability

60

💰 Cash Runway

65

📊 Float Risk

20

⚠️ Warrant Exposure

50

🔄 Convertible Debt

40

Dilution Forecast

⛅

Watch

Minor dilution signals detected

model est. 21%

💰 Capital Raise model 33%

• Under 12 months cash (7mo)

• Active ATM program with $200M remaining capacity

📜 Warrant Exercise model 15%

• Warrant overhang: 10.6% of shares outstanding

🔔 Track CRVS — Get forecast alerts →

Market Data

Market Cap$1.04B

Shares Outstanding84.12M

Float72.79M

Cash$18.91M

Debt$834.0K

Short InterestN/A

Institutional Holdings

QoQ: ↑ 75.6% shares (2026Q1 vs prior)

167 institutional holders · 85.55M shares

#1 ORBIMED ADVISORS LLC 7.17M shares

#2 MORGAN STANLEY 6.68M shares

#3 VANGUARD CAPITAL MANAGEMENT LLC 6.47M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest18.31M

Days to Cover22.5

% of Float25.2%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31

xbrl XBRL CONVERTIBLE 2025-12-31

8-K 8K EVENT 2026-04-23

424B5 ATM 2026-03-13

8-K 8K EVENT 2026-03-13

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual CRVS Dilution Snapshot

Corvus Pharmaceuticals, Inc. (CRVS) has a DilutionScore of 59/100, rated High dilution risk. Score date: August 28, 2026.

Stored ATM program remaining capacity: $200.0M.
Stored outstanding warrants: 8.9M.
Recent SEC activity tracked for CRVS: 8-K on 2026-04-23; 424B5 on 2026-03-13; 8-K on 2026-03-13.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.